Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationMultiple MyelomaAmyloidosisHematopoietic Stem Cell MobilizationMelphalanTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorCombined Modality TherapyLeukapheresisAntigens, CD34Hematologic NeoplasmsBlood Component RemovalStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideMyeloablative AgonistsTreatment OutcomeBusulfanGraft vs Host DiseaseLymphoma, Non-HodgkinRemission InductionBone Marrow TransplantationGraft SurvivalAntineoplastic Agents, AlkylatingHematopoietic Stem CellsRecurrenceEtoposideThiotepaSalvage TherapyVincristineCarmustineCytophagocytosisDisease-Free SurvivalIfosfamideBoronic AcidsPyrazinesThalidomideSurvival RateRetrospective StudiesDexamethasoneStem CellsCytarabineHematopoiesisHodgkin DiseaseCord Blood Stem Cell TransplantationPrednisoneSurvival AnalysisTransplantation ChimeraDoxorubicinNeoplasmsTissue DonorsTime FactorsWhole-Body IrradiationInfectionLymphoma, T-CellAntineoplastic AgentsPOEMS SyndromePlatelet CountHistocompatibilityBone MarrowFollow-Up StudiesHistocompatibility TestingCarboplatinImmunosuppressive AgentsPlasma CellsLeukemia, Myeloid, AcuteBone Marrow PurgingTransplantation, IsogeneicVidarabineBlood Cell CountRecombinant ProteinsLeukemiaFatal OutcomeAmyloidosis, FamilialPrognosisLymphomaImmunophenotypingProspective StudiesBlood CellsCytomegalovirus InfectionsGraft vs Leukemia EffectFeasibility StudiesMyeloma ProteinsParaproteinemiasMyelodysplastic SyndromesFlow CytometryAnemia, AplasticBlood Transfusion, AutologousLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionBone Marrow CellsHematologic DiseasesLeukocytes, MononuclearT-LymphocytesOpportunistic InfectionsHistiocytosis, Non-Langerhans-Cell